SCHEMBL2656033

SCHEMBL2656033

CCOC(=O)Cc1csc(NC(=O)C(Oc2ccc(F)c(Cl)c2)c2ccc(S(=O)(=O)C3CC3)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 4/20 0.47
POLB P06746 2/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 6/20 0.46
LMNA P02545 2/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 2/20 0.44
GCK P35557 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766570 0.92 KMT2A (0.56) KMT2ASMN1; SMN2GAAHPGDMEN1
SCHEMBL2657532 0.90 GCK (0.52) KMT2AMEN1MAPTGCK
SCHEMBL2669427 0.90 KMT2A (0.56) KMT2ASMN1; SMN2MEN1POLBPKM
SCHEMBL3805122 0.89 SMN1; SMN2 (0.51) KMT2ASMN1; SMN2GAAHPGDMEN1
SCHEMBL2658480 0.87 GCK (0.48) GCK
SCHEMBL3768825 0.86 GCK (0.58) KMT2AMEN1ALDH1A1MAPTTDP1
SCHEMBL3768120 0.83 GCK (0.55) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL16456839 0.83 GCK (0.55) KMT2ASMN1; SMN2MEN1POLBALDH1A1
SCHEMBL2657190 0.81 GCK (0.47) GCK
SCHEMBL3808008 0.81 GCK (0.58) KMT2ASMN1; SMN2GAAHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195304-B1 ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATIONS ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2014-01-08 EP claimed
US-8501955-B2 Acetamide derivatives as glucokinase activators, their process and medicinal application ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2013-08-06 US claimed
EP-2195304-A2 ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATIONS Advinus Therapeutics Private Limited (IN) 2010-06-16 EP claimed
WO-2009047798-A2 ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATIONS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2009-04-16 WO claimed
EP-2195304-B1 ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATIONS ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2014-01-08 EP disclosed